Oracle on Thursday said it has acquired SiteWorks Solutions, a Memphis, Tenn.-based maker of software for clinical trial management. The database company said it will integrate SiteWorks' products, SiteMinder and TrialMinder, into its products for clinical trials. Financial details of the deal were not disclosed.
Oracle's clinical products are designed to help drug companies handle a number of parallel clinical studies, eliminate redundancy in remote data capture, track adverse events from different sources, summarize medical terminology and respond to regulatory queries. "Pharmaceutical companies need to reduce the $800 million cost of producing a new drug, and research institutions need to operate more efficiently in order to be attractive to those pharmaceutical companies," Keith Howells, VP of Oracle's pharmaceutical applications effort, said in a statement.
Everything Apple announced today: What we know about Apple's TV content and service, credit card, game subscription service and more.
Apple TV Channel's streaming service is here: Get ready for another way to watch your shows in an already crowded battle for your views.
Discuss: Oracle buys clinical trial software maker
Be respectful, keep it civil and stay on topic. We delete comments that violate our policy, which we encourage you to read. Discussion threads can be closed at any time at our discretion.